Bromide

Bromide

SCHEMBL4792607

Br.Cc1cc(O)cc(Oc2nnn[nH]2)c1.N#CC#N

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 1/20 0.38
POLB P06746 1/20 0.35
CYP2C9 P11712 1/20 0.35
ALDH1A1 P00352 1/20 0.32
KCNH2 Q12809 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5106372 0.93 PTPN1 (0.42) PTPN1POLBCYP2C9ALDH1A1
SCHEMBL11205508 0.82 BACE1 (0.35)
Diorcinol SCHEMBL28744720 0.69 ALDH1A1 (0.60) PTPN1POLBALDH1A1
Diorcinol SCHEMBL29629136 0.69 ALDH1A1 (0.60) PTPN1POLBALDH1A1
SCHEMBL11204242 0.69 ALDH1A1 (0.42) CYP2C9ALDH1A1
SCHEMBL11710182 0.65 ALDH1A1 (0.48) PTPN1POLBALDH1A1
SCHEMBL9505524 0.62 ALDH1A1 (0.45) ALDH1A1
SCHEMBL27731949 0.61 AR (0.49) PTPN1ALDH1A1
SCHEMBL13119743 0.61 KCNH2 (0.43) PTPN1ALDH1A1KCNH2
SCHEMBL11209033 0.61 MAOB (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1963259-A2 SUBSTITUTED DIPHENYLETHERS, -AMINES, -SULFIDES AND -METHANES FOR THE TREATMENT OF RESPIRATORY DISEASE AstraZeneca AB (SE) 2008-09-03 EP disclosed
WO-2007068894-A2 SUBSTITUTED DIPHENYLETHERS, -AMINES, -SULFIDES AND -METHANES FOR THE TREATMENT OF RESPIRATORY DISEASE ASTRAZENECA AB (SE) 2007-06-21 WO disclosed